The Week

Affirm (AFRM) fell 1.26% this week to close at $71.44, lagging the S&P 500 by about 0.46 percentage points. The four-session week started quietly on Tuesday at $72.08, broke lower to $68.15 on Wednesday, and hit a 60-day range low of $66.03 on Thursday before buyers stepped in on Friday to lift the stock back to $71.44. Daily turnover averaged roughly 4.3m shares, about 17.6% above the median, indicating heavier-than-usual trading. The 60-day range high of $90.44 was set on 28 August, while Friday’s close remained below the 20-day average of $74.36 and the 60-day average of $76.29.

Key Events

The most direct company-specific development this week was insider selling. On 10 September, Affirm Chief Accounting Officer Jiyane Siphelele disposed of 25,000 common shares worth roughly $1.81m, drawing follow-up coverage the next day under headlines about a top executive’s move shaking up Affirm Holdings. On the product side, Flex Dental Solutions launched a buy now, pay later offering inside FlexPayments in partnership with Affirm and Klarna, adding a surcharge feature. At the industry level, several reports this week described institutional rotation: Wall Street paying for hard AI infrastructure and weight-loss drugs while reassessing other sectors, with Jim Cramer suggesting investors are too focused on AI names. These macro and rotation signals broadly coincided with Thursday’s intraday low, though Affirm had no earnings report or major filing this week, so the link between the selling and the price action should be treated as coincident rather than causal.

Analyst Ratings

Affirm is covered by 35 institutions: 20 rate it buy, 6 rate it overweight, and 9 rate it hold, with no underweight or sell ratings. The consensus recommendation is buy, and the consensus target of $99.3871 sits about 39.1% above the latest close of $71.44. The target range is wide: the low end of $66 is near the current price, while the high end of $124 implies substantial upside, pointing to meaningful dispersion among brokers. Within the transaction and payment services industry of 45 companies, Affirm ranks 7th, above the industry median.

The Week Ahead

Next week brings several US retail and manufacturing data points. On Tuesday 15 September, the New York Fed manufacturing index is due, with a prior reading of 20.6 and a forecast of 14.75. Wednesday 16 September is busier: retail sales excluding autos (prior -0.3, forecast 0.6), retail control (prior -0.4, forecast 0.4), retail sales (prior -0.6, forecast 0.9), import prices, and the NAHB housing market index. Consumer-related data are relevant to buy now, pay later demand expectations, and the retail prints may influence how the market prices payment names. Affirm itself has no disclosed earnings or major event on the calendar.

In Short

This week set falling share prices against a broadly constructive analyst picture. The close sits not far from the lower end of the 60-day range, while the consensus target is about 39% above spot and none of the 35 covering institutions rate the stock underweight or sell. At the same time, the latest session’s flow data leaned net seller in large and medium lots and net buyer in small lots, with the stock at about 12.49x P/E and 4.40x P/B. Insider selling and rotation chatter added near-term noise, while next week’s retail data will test whether consumer resilience supports the payment complex.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.